Abstract Lipoprotein (a)[Lp (a)] is a highly heritable cardiovascular risk factor. Although
discovered more than 50 years ago, Lp (a) has recently re-emerged as a major focus in the …

Plasma and serum biochemical markers proposed for cognitive decline of degenerative
(Alzheimer's disease, AD) or vascular origin and predementia syndromes (mild cognitive …

Recently published epidemiological and genetic studies strongly suggest a causal
relationship of elevated concentrations of lipoprotein (a)[Lp (a)] with cardiovascular disease …

Plasma lipoprotein (a)(Lp [a]) level is an independent risk factor of cardiovascular disease
that is under strong genetic control. We conducted a genome-wide association study of …

Lipoprotein (a) is an apolipoprotein B100-containing low-density lipoprotein-like particle that
is rich in cholesterol, and is associated with a second major protein, apolipoprotein (a) …

Stroke is one of the most common causes of death and long term disability throughout the
world. It may be the outcome of a number of monogenic disorders or, more commonly, a …

Background and Purpose—It is still inconclusive whether high plasma lipoprotein (a)[Lp (a)]
level is a risk factor for stroke. Small sample size and different ethnic groups and …

Two independent single-nucleotide polymorphisms (SNPs) in the gene encoding
apolipoprotein (a)(LPA) have been shown to be associated with coronary heart disease …

Abstract Lipoprotein (a)[Lp (a)] is an independent risk factor for atherosclerosis-related
events that is under strong genetic control (heritability= 0.68–0.98). However, causal …

Objective—Lp (a)(lipoprotein (a)) concentrations are widely genetically determined by the
LPA isoforms and show 5-fold interpopulation differences. Two-to 3-fold differences have …